Related Experiment Videos
Ionic perturbation of agonist binding to brain muscarinic receptors [proceedings]
British Journal of Pharmacology
|July 1, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Changes in the Permeability of the Salivary Gland Caused by Sympathetic Stimulation and by Catecholamines.
The Journal of general physiology·2009
The action of acetylcholine and other drugs on the efflux of potassium and rubidium from smooth muscle of the guinea-pig intestine.
British journal of pharmacology·2008
Phenotypic classification of mutants: a tool for understanding ligand binding and activation of muscarinic acetylcholine receptors.
Biochemical Society transactions·2007
The hydration of the neurotransmitter acetylcholine in aqueous solution.
Biophysical journal·2006
Scanning mutagenesis studies of the M1 muscarinic acetylcholine receptor.
Receptors & channels·2003
Structure and activation of muscarinic acetylcholine receptors.
Biochemical Society transactions·2003
Zebrafish in the era of single-cell and spatial transcriptomics: a new paradigm for central nervous system drug discovery from natural products.
British journal of pharmacology·2026
TRPM3 regulates fear memory encoding and seizure susceptibility in the lateral amygdala.
British journal of pharmacology·2026
Bioengineered microbiotic levodopa therapy improves cognition and reduces pathology in a rat model of Alzheimer's disease.
British journal of pharmacology·2026
Natural product-derived TRPM7 channel inhibitors in neurological injury: Mechanisms, pharmacological potential and translational challenges.
British journal of pharmacology·2026
Alamandine/MrgD pathway modulates gut-bone marrow axis in ageing.
British journal of pharmacology·2026
Clustered cytoneme interactions contribute to peripheral nervous system patterning in Drosophila.
bioRxiv : the preprint server for biology·2026
Semaphorin 3G (SEMA3G) is a highly selective marker of cerebral amyloid angiopathy.
bioRxiv : the preprint server for biology·2026
Characterizing two nanobodies for SMAD4.
FEBS letters·2026
Untargeted Metabolomics Reveal New Endogenous Plasma Biomarkers Associated with CYP3A Inhibition in Humans.
Clinical pharmacology and therapeutics·2026